Skip to content
Unrated Drug recall · FDA · Published June 10, 2022

Macleods Pharma Losartan-Hydrochlorothiazide Tablets Recall: AZIDO Impurity Risk

Macleods Pharma recalls Losartan-Hydrochlorothiazide tablets due to AZIDO impurity levels exceeding safety limits. Affected lots may pose health risks if taken.

🇺🇸 FDA recall #D-1164-2022DrugMacleods Pharma ›
Take action

Contact the company

Recalling firmMacleods Pharma Usa Inc666 Plainsboro Rd Bldg 200 Ste 230 · Plainsboro, NJ 08536-0009
✎ GovInfoNow plain-language explainer

Macleods Pharma is recalling Losartan potassium and Hydrochlorothiazide tablets that contain unsafe levels of an AZIDO impurity. This could cause health risks if taken as prescribed. Read more at govinfonow.com/recall/34630-macleods-pharma-losartan-hydrochlorothiazide-tablets-recall-azido-impurity-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/34630-macleods-pharma-losartan-hydrochlorothiazide-tablets-recall-azido-impurity-risk · Updated September 23, 2026 · FDA enforcement record: FDA #D-1164-2022

Cite this page

“Macleods Pharma Losartan-Hydrochlorothiazide Tablets Recall: AZIDO Impurity Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/34630-macleods-pharma-losartan-hydrochlorothiazide-tablets-recall-azido-impurity-risk. Based on FDA recall #D-1164-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1164-2022%22&limit=1).

The FDA announced on June 10, 2022, that Macleods Pharma USA Inc voluntarily recalled Losartan potassium & Hydrochlorothiazide Tablets due to azido impurity levels exceeding acceptable limits. The recall affects specific lots distributed nationwide.

How to tell if you have it

  • Brand: Macleods Pharma
  • Product: Losartan potassium & Hydrochlorothiazide Tablets 100 mg/25 mg
  • NDC # 33342-052-07, NDC #33342-052-10 & NDC # 33342-052-44
  • Lot # BLM2114A
  • Expiration date: 07/2023
  • Manufacturer: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

The hazard

The recall was initiated because current Good Manufacturing Practice (CGMP) deviations resulted in azido impurity levels observed to be above acceptable limits. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Macleods Pharma USA, INC has 20 other recalls on record since 2015-12-24. Other recent recalls of similar products include Macleods Levothyroxine Tablets Recall (2026-02-26), Macleods Losartan/HCTZ Recall (2024-05-07), and Macleods Pharma Levofloxacin Tablets Recall (2023-01-05). Additional recent recalls include Unichem Bisoprolol/Hydrochlorothiazide Tablets Recall (2026-01-21), Macleods Olanzapine Tablets 5mg Recall (2026-08-27), and Ajanta Pharma Fluphenazine Tablets Recall (2026-08-25).

How to tell if you have this one

Check the product label for the specific lot numbers: NDC #33342-052-07, -10, or -44. The tablets are prescription-only and come in 30, 90, or 1000-count packages.

  • Brand
    Macleods Pharma
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the lot numbers NDC #33342-052-07, -10, or -44 on the tablet packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Product was distributed nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 23 months after the firm started it.

1. Firm started the recall: Jun 10, 202212. FDA classified it Class II: Jun 27, 202223. Published in FDA’s Enforcement Report: Jul 6, 202234. FDA terminated the recall: May 23, 2024420222024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Macleods Pharma recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1164-2022 (June 10, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1164-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA